100019-37-2 Usage
Description
(9Z)-11-(2R)-2-[(3E)-pent-3-en-1-yl]oxiran-2-ylundec-9-enoic acid is a long-chain unsaturated fatty acid characterized by the presence of a carboxylic acid group and a hydrocarbon chain with an epoxide ring and multiple double bonds. (9Z)-11-(2R)-2-[(3E)-pent-3-en-1-yl]oxiran-2-ylundec-9-enoic acid's name reflects its structural features, with (9Z), (2R), and (3E) indicating the geometry and stereochemistry of the double bonds and substituents on the epoxide ring. This chemical compound is found in certain plant and animal tissues and is believed to have potential biological activities due to its structure, possibly functioning as a signaling molecule or a component of cell membranes. Further research is being conducted to explore its specific physiological roles and potential applications in medicine and industry.
Uses
Used in Pharmaceutical Industry:
(9Z)-11-(2R)-2-[(3E)-pent-3-en-1-yl]oxiran-2-ylundec-9-enoic acid is used as a potential therapeutic agent for various medical conditions due to its unique structural features and potential biological activities. (9Z)-11-(2R)-2-[(3E)-pent-3-en-1-yl]oxiran-2-ylundec-9-enoic acid's presence in plant and animal tissues suggests it may play a role in cellular signaling or membrane function, which could be harnessed for the development of new drugs or therapies.
Used in Cosmetic Industry:
As a long-chain unsaturated fatty acid with an epoxide ring and multiple double bonds, (9Z)-11-(2R)-2-[(3E)-pent-3-en-1-yl]oxiran-2-ylundec-9-enoic acid may be used as an ingredient in the cosmetic industry for its potential moisturizing, anti-inflammatory, or antioxidant properties. These properties could be beneficial in the development of skincare products, hair care products, or other personal care items.
Used in Research and Development:
(9Z)-11-(2R)-2-[(3E)-pent-3-en-1-yl]oxiran-2-ylundec-9-enoic acid is used as a subject of ongoing research and investigation in both academic and industrial settings. Its unique structure and potential biological activities make it an interesting candidate for studying cellular processes, membrane dynamics, and the development of new pharmaceuticals or other applications.
Used in Nutritional Supplements:
Given its presence in plant and animal tissues, (9Z)-11-(2R)-2-[(3E)-pent-3-en-1-yl]oxiran-2-ylundec-9-enoic acid may be used as an ingredient in nutritional supplements, particularly those targeting heart health, inflammation, or general wellness. Its role in cell signaling and membrane function could potentially contribute to the overall health benefits of these supplements.
Check Digit Verification of cas no
The CAS Registry Mumber 100019-37-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,0,1 and 9 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 100019-37:
(8*1)+(7*0)+(6*0)+(5*0)+(4*1)+(3*9)+(2*3)+(1*7)=52
52 % 10 = 2
So 100019-37-2 is a valid CAS Registry Number.
100019-37-2Relevant articles and documents
Oxidation of C18 Hydroxy-Polyunsaturated Fatty Acids to Epoxide or Ketone by Catalase-Related Hemoproteins Activated with Iodosylbenzene
Teder, Tarvi,Boeglin, William E.,Brash, Alan R.
, p. 587 - 597 (2017/06/30)
Small catalase-related hemoproteins with a facility to react with fatty acid hydroperoxides were examined for their potential mono-oxygenase activity when activated using iodosylbenzene. The proteins tested were a Fusarium graminearum 41?kD catalase hemoprotein (Fg-cat, gene FGSG_02217), a Pseudomonas fluorescens Pfl01 catalase (37.5?kD, accession number WP_011333788.1), and a Mycobacterium avium ssp. paratuberculosis 33?kD catalase (gene MAP-2744c). 13-Hydroxy-octadecenoic acids (which are normally unreactive) were selected as substrates because these enzymes react specifically with the corresponding 13S-hydroperoxides (Pakhomova et al. 18:2559–2568, 5; Teder et al. 1862:706–715, 14). In the presence of iodosylbenzene Fg-cat converted 13S-hydroxy-fatty acids to two products: the 15,16-double bond of 13S-hydroxy α-linolenic acid was oxidized stereospecifically to the 15S,16R-cis-epoxide or the 13-hydroxyl was oxidized to the 13-ketone. Products were identified by UV, HPLC, LC–MS, NMR and by comparison with authentic standards prepared for this study. The Pfl01-cat displayed similar activity. MAP-2744c oxidized 13S-hydroxy-linoleic acid to the 13-ketone, and epoxidized the double bonds to form the 9,10-epoxy-13-hydroxy, 11,12-epoxy-13-hydroxy, and 9,10-epoxy-13-keto derivatives; equivalent transformations occurred with 9S-hydroxy-linoleic acid as substrate. In parallel incubations in the presence of iodosylbenzene, human catalase displayed no activity towards 13S-hydroxy-linoleic acid, as expected from the highly restricted access to its active site. The results indicated that with suitable transformation to Compound I, monooxygenase activity can be demonstrated by these catalase-related hemoproteins with tyrosine as the proximal heme ligand.
